Clinical Trials Logo

Marginal Ulcer clinical trials

View clinical trials related to Marginal Ulcer.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT03163680 Completed - Clinical trials for Peptic Ulcer Hemorrhage

Efficacy of Low Dose of Proton Pump Inhibitor in Treatment Bleeding Ulcers

Start date: January 2012
Phase:
Study type: Observational

Determining the efficacy of low dose of PPI in management acute peptic ulcer bleeding

NCT ID: NCT01041196 Completed - Marginal Ulcer Clinical Trials

Perforated Marginal Ulcer After Gastric Bypass

PerforatedMU
Start date: January 2009
Phase: N/A
Study type: Observational

A common late complication after gastric bypass surgery is marginal ulceration that is defined as ulcers at the margins of the gastrojejunostomy, mostly on the jejunal side. Most marginal ulcers respond to medical therapy and complicated or complex ulcer disease warrants operative intervention; specifically, perforated, penetrated, obstructing, bleeding and intractable marginal ulcers require surgical intervention. Diverse operative strategies for addressing perforated marginal ulcers after gastric bypass have been described including I) Omental (Graham) patch repair, II) Revision of gastrojejunostomy, III) Irrigation and drainage, IV) any previous procedure with truncal vagotomy, V) Esophagojejunostomy, and VI) Reversal. We formally analyze our experience with the laparoscopic resection and repair of acutely perforated marginal ulcers after Roux-en-Y gastric bypass (RYGB), with or without concomitant resolution of technical risk factors for marginal ulceration.

NCT ID: NCT01041079 Completed - Marginal Ulcer Clinical Trials

Chronic Marginal Ulcers After Gastric Bypass

ChronicMU
Start date: December 2008
Phase: N/A
Study type: Observational

The purpose of this study is to determine the feasibility, safety, and efficacy of revision gastroplasty along with other adjunct procedures in the treatment of intractable / chronic marginal ulcers after Roux-en-Y gastric bypass. A secondary aim is the identification of good and poor outcome predictors after revisional strategies for intractable or chronic marginal ulcer.